Stay updated on EDP-305 Safety and Efficacy in NASH Clinical Trial
Sign up to get notified when there's something new on the EDP-305 Safety and Efficacy in NASH Clinical Trial page.

Latest updates to the EDP-305 Safety and Efficacy in NASH Clinical Trial page
- Check3 days agoChange DetectedThe site footer revision changed from v3.7.1 to v3.7.2 while the study page continues to show a 403 error.SummaryDifference0.2%

- Check10 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study record details. The header and footer of ClinicalTrials.gov remain visible, indicating restricted access to the study entry.SummaryDifference19%

- Check52 days agoChange DetectedThe page now includes the 2019 NIH grant/contract attribution. The site revision has been updated to v3.6.6, replacing the previous v3.6.5.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page now displays an error indicating the content is unavailable, preventing access to the study details. Added study documents and metadata (Protocol PDF, SPA PDF, IPD plan, and related information) to provide additional resources when the page loads correctly.SummaryDifference98%

- Check74 days agoChange DetectedThe page now displays Revision: v3.6.5, signaling a newer site version, and the older Revision: v3.6.4 label has been removed.SummaryDifference18%

Stay in the know with updates to EDP-305 Safety and Efficacy in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EDP-305 Safety and Efficacy in NASH Clinical Trial page.